Market Place
Sourcing Support
SOM Biotech Advances SOM3355 For Huntington`s Disease With FDA
20 Oct 2025 //
PHARMIWEB
SOM Biotech Gets EMA COMP Nod for SOM3355 in Huntington`s Disease
15 Sep 2025 //
PHARMAWEB
SOM Biotech signs licensing agreement with the University of Minnesota
16 May 2022 //
GLOBENEWSWIRE
SOM Biotech granted Orphan Drug Designation by the FDA for SOM3355
18 Oct 2021 //
GLOBENEWSWIRE
SOM Biotech presents positive Phase 2a data with SOM3355 at the 34th
04 Oct 2021 //
GLOBENEWSWIRE
SOM Biotech presents positive Phase 2a data with SOM3355 at the 34th
04 Oct 2021 //
GLOBENEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.